title: Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.
abstract: Attention deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavioral disorder in children and adolescents, and in about half of these patients, significant symptomology continues into adulthood. Although impulsivity and hyperactivity are the most salient features of ADHD, cognitive deficits, particularly impairments in attention and executive function, are an important component, particularly in adolescents and adults, with over 90% of adults seeking treatment for ADHD manifesting cognitive dysfunction. Currently available medications treat the core ADHD symptoms but typically do not adequately address cognitive aspects of ADHD, underscoring the need for new therapeutics. Dopamine and norepinephrine are hypothesized to be particularly important in ADHD, but there is emerging evidence that cholinergic neurotransmission, particularly involving neuronal nicotinic acetylcholine receptors (nAChRs), may play a role in the pathophysiology of ADHD. Nicotine has demonstrated procognitive effects in both humans and experimental animals and has produced signals of efficacy in small proof-of-concept adult ADHD trials. Although adverse effects associated with nicotine preclude its development as a therapeutic, a number of novel nAChR agonists with improved safety/tolerability profiles have been discovered. Of these, ABT-418 and ABT-089 have both demonstrated signals of efficacy in adults with ADHD. Notably, tolerability issues that might be expected of a nAChR agonist, such as nausea and emesis, were not observed at efficacious doses of ABT-089. Further understanding of the effects of novel neuronal nAChR agonists on specific aspects of cognitive functioning in ADHD is required to assess the full potential of this approach.
authors: Massachusetts General Hospital, Pediatric Psychopharmacology Research Unit, Yawkey Center for Outpatient Care-YAW 6A, Boston, MA 02114, USA. twilens@partners.org
authors: Timothy E
authors: TE
authors: Wilens
authors: Michael W
authors: MW
authors: Decker
mesh_terms: D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D003071:Cognition / Q000187:drug effects*; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D018722:Nicotinic Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use*; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000502:physiology; D009435:Synaptic Transmission
chemical_list: D007555:Isoxazoles; D018722:Nicotinic Agonists; D011725:Pyridines; D011759:Pyrrolidines; D011978:Receptors, Nicotinic; C088383:3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole; C108326:pozanicline
references: Behav Brain Res. 2006 Dec 15;175(2):201-11
references: 17081628
references: Eur J Pharmacol. 1987 Sep 23;141(3):395-9
references: 3666033
references: J Subst Abuse. 1995;7(3):373-8
references: 8749796
references: J Child Psychol Psychiatry. 1996 Jan;37(1):51-87
references: 8655658
references: Psychopharmacology (Berl). 1999 Mar;142(4):334-42
references: 10229057
references: J Am Acad Child Adolesc Psychiatry. 1995 Mar;34(3):336-47
references: 7896676
references: Curr Med Chem. 2006;13(13):1567-84
references: 16787204
references: Annu Rev Pharmacol Toxicol. 2002;42:135-63
references: 11807168
references: Life Sci. 1995;56(8):545-70
references: 7869835
references: J Child Psychol Psychiatry. 1977 Apr;18(2):137-65
references: 326801
references: Arch Neurol. 1990 Aug;47(8):919-26
references: 2375699
references: Biol Psychiatry. 1999 Jun 15;45(12):1542-52
references: 10376114
references: Psychopharmacology (Berl). 2000 Apr;149(3):293-305
references: 10823411
references: Annu Rev Neurosci. 1993;16:403-43
references: 7681637
references: Neuropsychopharmacology. 2007 Jan;32(1):17-34
references: 16936709
references: JAMA. 1998 Apr 8;279(14):1100-7
references: 9546570
references: Psychopharmacology (Berl). 1984;82(4):338-42
references: 6427826
references: Psychopharmacology (Berl). 1998 Mar;136(1):50-8
references: 9537682
references: Neuropsychopharmacology. 2002 Sep;27(3):479-97
references: 12225705
references: N Engl J Med. 1999 Jan 7;340(1):40-6
references: 9878644
references: Prog Neurobiol. 2004 Dec;74(6):363-96
references: 15649582
references: Arch Gen Psychiatry. 1996 May;53(5):437-46
references: 8624187
references: Arch Gen Psychiatry. 1993 Jul;50(7):565-76
references: 8317950
references: Neurobehav Toxicol Teratol. 1982 May-Jun;4(3):365-9
references: 7099355
references: Behav Brain Res. 2002 Mar 10;130(1-2):3-28
references: 11864714
references: Am J Psychiatry. 1998 Oct;155(10):1358-64
references: 9766767
references: Arch Gen Psychiatry. 1975 Jun;32(6):790-5
references: 1093506
references: J Child Adolesc Psychopharmacol. 2005 Dec;15(6):996-1004
references: 16379520
references: Psychopharmacology (Berl). 2003 Jul;168(3):271-9
references: 12698230
references: J Nerv Ment Dis. 1979 May;167(5):288-97
references: 448331
references: Arch Gen Psychiatry. 2001 Mar;58(3):289-95
references: 11231836
references: J Atten Disord. 2002 Mar;5(4):203-9
references: 11967476
references: Psychopharmacology (Berl). 2004 Nov;176(2):182-94
references: 15083253
references: Am J Psychiatry. 1999 Dec;156(12):1931-7
references: 10588407
references: Nicotine Tob Res. 2006 Feb;8(1):37-47
references: 16497598
references: CNS Drugs. 2004;18(6):397-401
references: 15089111
references: World Psychiatry. 2003 Jun;2(2):104-13
references: 16946911
references: Psychopharmacology (Berl). 1996 Jan;123(1):55-63
references: 8741955
references: J Clin Psychiatry. 1998;59 Suppl 7:17-23
references: 9680049
references: J Pharmacol Exp Ther. 1997 Oct;283(1):235-46
references: 9336329
references: Psychopharmacology (Berl). 2006 Mar;184(3-4):523-39
references: 16220335
references: J Abnorm Child Psychol. 1995 Aug;23(4):411-37
references: 7560554
references: Psychiatry Res. 1995 Jan 31;56(1):59-70
references: 7792343
references: Am J Psychiatry. 2006 Oct;163(10):1730-8
references: 17012683
references: Psychopharmacology (Berl). 1984;84(2):205-16
references: 6438679
references: CNS Drug Rev. 2004 Summer;10(2):167-82
references: 15179445
references: J Am Acad Child Adolesc Psychiatry. 1990 Jul;29(4):546-57
references: 2387789
references: J Clin Psychopharmacol. 1999 Jun;19(3):257-64
references: 10350032
references: Behav Neurosci. 1987 Aug;101(4):457-64
references: 2820435
references: Compr Psychiatry. 1980 Sep-Oct;21(5):358-69
references: 6774849
references: Am J Psychiatry. 1994 May;151(5):665-9
references: 8166306
references: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9596-601
references: 12876201
references: Alzheimer Dis Assoc Disord. 1995;9 Suppl 2:50-61
references: 8534424
references: Psychopharmacology (Berl). 1995 Jun;119(4):368-75
references: 7480515
references: Pharmacol Ther. 1983;21(2):189-208
references: 6353441
references: J Child Neurol. 1993 Oct;8(4):339-47
references: 8228029
references: J Am Acad Child Adolesc Psychiatry. 1995 Jul;34(7):886-96
references: 7649959
references: Physiol Behav. 2006 Mar 30;87(3):614-24
references: 16466655
references: J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S
references: 11833633
references: Prog Neurobiol. 2002 Dec;68(5):341-60
references: 12531234
references: J Child Psychol Psychiatry. 1995 Nov;36(8):1459-73
references: 8988278
references: J Psychopharmacol. 2007 Mar;21(2):171-8
references: 17329297
references: Int Clin Psychopharmacol. 1986 Jan;1(1):45-52
references: 3549871
references: J Learn Disabil. 1991 Dec;24(10):630-6
references: 1783870
references: Neuroscience. 2004;129(1):11-24
references: 15489024
references: J Consult Clin Psychol. 1997 Feb;65(1):150-160
references: 9103744
references: Psychopharmacology (Berl). 1989;97(2):257-61
references: 2498936
references: Clin Neuropsychol. 1999 Feb;13(1):12-21
references: 10937644
references: Brain Res Brain Res Rev. 2005 Feb;48(1):98-111
references: 15708630
references: Am J Psychiatry. 2001 Jul;158(7):1052-7
references: 11431226
references: J Abnorm Child Psychol. 1991 Feb;19(1):35-52
references: 2030246
references: CNS Drug Rev. 2004 Summer;10(2):147-66
references: 15179444
references: Synapse. 1991 Feb;7(2):151-68
references: 1672782
references: Pharmacol Biochem Behav. 2005 Nov;82(3):539-48
references: 16360813
references: J Am Acad Child Psychiatry. 1985 Mar;24(2):211-20
references: 3989165
references: J Am Acad Child Adolesc Psychiatry. 1997 Jan;36(1):37-44
references: 9000779
references: Psychopharmacol Bull. 1996;32(1):67-73
references: 8927677
references: Trends Pharmacol Sci. 2000 Jun;21(6):211-7
references: 10838608
references: J Neurosci. 2002 Mar 1;22(5):1905-13
references: 11880520
references: J Med Chem. 2006 Jul 13;49(14):4374-83
references: 16821797
references: J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):754-63
references: 9183129
references: J Abnorm Child Psychol. 1995 Dec;23(6):729-49
references: 8609310
references: J Clin Exp Neuropsychol. 2000 Feb;22(1):115-24
references: 10649550
references: J Am Acad Child Adolesc Psychiatry. 1995 Aug;34(8):1015-24
references: 7665440
references: Pediatrics. 1987 Oct;80(4):491-501
references: 3658567
references: Mol Psychiatry. 2003 Jan;8(1):103-8
references: 12556914
references: J Atten Disord. 2009 Sep;13(2):161-7
references: 19420282
references: J Atten Disord. 2002 Mar;5(4):189-202
references: 11967475
references: Gen Pharmacol. 1983;14(3):321-5
references: 6135645
references: Trends Pharmacol Sci. 2006 Sep;27(9):482-91
references: 16876883
references: Psychopharmacology (Berl). 1988;95(2):171-5
references: 3137593
references: Child Psychiatry Hum Dev. 1986 Summer;16(4):221-34
references: 3743175
references: Int J Neuropsychopharmacol. 2002 Jun;5(2):111-3
references: 12135534
references: Brain Res. 1996 Apr 1;714(1-2):185-91
references: 8861624
references: Biol Psychiatry. 2006 Jun 1;59(11):1065-70
references: 16499880
references: J Consult Clin Psychol. 1990 Oct;58(5):580-8
references: 2254504
references: JAMA. 2004 Aug 4;292(5):619-23
references: 15292088
references: Pediatrics. 1989 Oct;84(4):648-57
references: 2780127
references: J Pediatr. 1981 Jun;98(6):912-5
references: 7229792
references: Psychol Bull. 1997 Jan;121(1):65-94
references: 9000892
references: Neurosci Lett. 2006 Dec 13;410(1):15-9
references: 17055644
references: Trends Neurosci. 1997 Feb;20(2):92-8
references: 9023878
references: J Child Adolesc Psychopharmacol. 2005 Aug;15(4):664-70
references: 16190797
references: Am J Psychiatry. 1994 Dec;151(12):1791-6
references: 7977887
references: Annu Rev Pharmacol Toxicol. 2004;44:269-96
references: 14744247
references: Arch Clin Neuropsychol. 1999 Feb;14(2):217-33
references: 14590604
references: Brain Res Brain Res Rev. 1998 May;26(2-3):198-216
references: 9651527
references: J Clin Psychol. 1989 Jul;45(4):619-32
references: 2768502
references: Am J Psychiatry. 2000 Jan;157(1):4-15
references: 10618007
references: N Engl J Med. 1990 Nov 15;323(20):1361-6
references: 2233902
references: Can J Psychiatry. 1986 Aug;31(6):557-67
references: 3756759
references: J Child Psychol Psychiatry. 2002 Sep;43(6):785-96
references: 12236613
references: Biol Psychiatry. 1998 Aug 15;44(4):260-8
references: 9715357
references: Child Adolesc Psychiatr Clin N Am. 2000 Jul;9(3):573-603, viii
references: 10944658
references: J Consult Clin Psychol. 2000 Jun;68(3):477-488
references: 10883564
references: Psychopharmacology (Berl). 2004 Apr;172(4):375-83
references: 14727003
references: Neuropsychopharmacology. 2004 Jul;29(7):1378-85
references: 15138435
references: Psychopharmacology (Berl). 1992;108(4):485-94
references: 1410164
references: Cereb Cortex. 1998 Mar;8(2):164-72
references: 9542895
references: J Am Acad Child Adolesc Psychiatry. 1995 Jul;34(7):877-85
references: 7649958
references: J Clin Psychiatry. 1998;59 Suppl 7:4-16
references: 9680048
references: J Med Chem. 2006 Jul 13;49(14):4425-36
references: 16821801
references: Neuropharmacology. 2003 Jun;44(8):1054-67
references: 12763099
references: J Am Acad Child Adolesc Psychiatry. 1997 Sep;36(9):1222-7
references: 9291723
references: Psychol Med. 1999 May;29(3):527-38
references: 10405075
references: Am J Psychiatry. 1996 Sep;153(9):1138-42
references: 8780415
references: Arch Gen Psychiatry. 2005 Oct;62(10):1142-7
references: 16203959
references: Am J Psychiatry. 2000 May;157(5):816-8
references: 10784477
references: J Pharmacol Exp Ther. 1997 Oct;283(1):247-58
references: 9336330
references: Am J Psychiatry. 1993 Dec;150(12):1792-8
references: 8238632
references: Compr Psychiatry. 1990 Sep-Oct;31(5):416-25
references: 2225800
references: J Abnorm Child Psychol. 1989 Oct;17(5):473-91
references: 2681316
references: Pharmacol Biochem Behav. 1989 May;33(1):1-6
references: 2780768